Early detection of clinically significant prostate cancer at diagnosis: a prospective study using a novel panel of TMPRSS2:ETS fusion gene markers

We explore noninvasive clinical applications of multiple disease-specific fusion markers recently discovered in prostate cancer to predict the risk of cancer occurrence and aggressiveness at diagnosis. A total of 92 men who were prostate-specific antigen (PSA) screened and scheduled for diagnostic b...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Sam W., Nguyen, Phuong-Nam, Violette, Philippe, Brimo, Fadi, Taguchi, Yosh, Aprikian, Armen, Chen, Junjian Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797559/
https://www.ncbi.nlm.nih.gov/pubmed/24133629
http://dx.doi.org/10.1002/cam4.49

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797559/
https://www.ncbi.nlm.nih.gov/pubmed/24133629
http://dx.doi.org/10.1002/cam4.49

Ejemplares similares